X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospace.com/article/releases/polyphor-closes-merger-with-enbiotix-and-is-renamed-spexis/?s=79
https://www.accesswire.com/662404/Polyphor-and-EnBiotix-Announce-Signing-of-Merger-Agreement-and-Sale-of-Inhaled-Murepavadin-to-EnBiotix
https://www.bloomberg.com/press-releases/2021-07-16/eqs-adhoc-polyphor-provides-update-on-the-future-of-the-fortress-study-of-balixafortide-and-announces-initial-restructuring
https://www.fiercebiotech.com/biotech/polyphor-flops-a-phase-3-jeopardizing-its-future-as-shares-more-than-halved
https://www.globenewswire.com/news-release/2021/06/28/2253544/0/en/Polyphor-Provides-Update-on-the-Phase-III-FORTRESS-Study-of-Balixafortide-in-Patients-With-Advanced-HER2-Negative-Breast-Cancer.html
https://www.fiercebiotech.com/research/a-breast-cancer-candidate-for-covid-19-polyphor-s-drug-shows-dual-action-early-studies
https://www.globenewswire.com/news-release/2020/12/14/2144199/0/en/Polyphor-Announces-Third-Positive-Data-Safety-Monitoring-Board-DSMB-Recommendation-to-Continue-Phase-III-balixafortide-FORTRESS-Study-Without-Modifications.html
https://www.fiercebiotech.com/biotech/polyphor-snags-3-3m-from-cysic-fibrosis-foundation-for-inhaled-antibiotic
https://www.globenewswire.com/news-release/2020/11/24/2132422/0/en/Polyphor-receives-award-of-up-to-USD-3-3-million-from-Cystic-Fibrosis-Foundation-to-support-clinical-development-of-inhaled-antibiotic-murepavadin.html
https://www.pharmiweb.com/press-release/2020-10-30/polyphor-completes-recruitment-in-phase-iii-trial-of-balixafortide-in-metastatic-breast-cancer
Market Place
Share 
